Skip to content

Home/Archive/PubMed

PubMed · 15172478

Cardioversion threshold, IRAF and beyond.

K L Merckx·R G Tieleman·H J G M Crijns

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Amiodarone Anti-Arrhythmia Agents Atrial Fibrillation Electric Countershock Flecainide Humans Verapamil Comment Letter

Keep this discovery

Explore connections, maps & timelines

K L Merckx, R G Tieleman, H J G M Crijns. 2004. Cardioversion threshold, IRAF and beyond.. https://doi.org/10.1016/j.ehj.2004.04.002

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Surgical correction of mitral valve prolapse : a cure for recurrent ventricular tachycardia in Marfan syndrome?

We describe the case of a 3-year-old child with neonatal Marfan syndrome complicated by mitral valve prolapse with regurgitation, marked aortic root dilatation, and ventricular tachycardia. The patient had resolution of ventricular tachycardia following surgical intervention consisting of a valve-sparing aortic root replacement and mitral valve annuloplasty.

Amiodarone↗

PubMed2006

Unmasking of the Brugada syndrome phenotype during the acute phase of amiodarone infusion.

Explore the source record for details and available documents.

Amiodarone↗

PubMed2006

Anti-inflammatory effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Potential benefits for the prevention of atrial fibrillation.

Explore the source record for details and available documents.

Amiodarone↗